Healthy volunteer
Conditions
Interventions
Intake of test-food (2 tablets) with (lukewarm) water, twice daily, for 8 weeks.
Sponsors
DKS Co. Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Men and women aged 35 to under 70 years at the time of providing consent to participate in the study. 2.Individuals whose written informed consent has been obtained. 3.Individuals judged appropriate for the study by the principal.
Exclusion criteria
Exclusion criteria: 1. Individuals with comorbid or suspected neurodegenerative diseases presenting dementia-like symptoms, such as Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, or multiple sclerosis. 2.Individuals undergoing hormone replacement therapy, including testosterone replacement therapy. 3.Individuals with a history of treatment for psychiatric disorders, sleep apnea syndrome, diabetes, taste disorders, anemia, or other serious illnesses within the past year. 4.Individuals with a history or current diagnosis of serious hepatic, renal, cardiac, pulmonary, hematologic, or other systemic diseases. 5.Individuals with serious comorbid or past gastrointestinal diseases. 6.Individuals who may experience allergic reactions to silkworm (silk), mushrooms, or other foods or medications. 7.Individuals who are currently, or have within the past month, habitually consumed foods containing Cordyceps sinensis, or health functional foods, dietary supplements, Foods for Specified Health Uses (FOSHU), or other health foods that are highly enriched with ingredients suggested to have similar effects to the investigational product-such as Cordyceps sinensis, isoflavones, Pycnogenol, zinc, Korean ginseng, maca extract, coenzyme Q10, ginkgo biloba extract,or DHA/EPA-or individuals who plan to consume such products during the study period. 8.Pregnant or lactating women, or women who intend to become pregnant during the study period. 9.Individuals currently participating in another clinical trial or who have participated in another clinical trial within the past three months. 10.Individuals who are unable to attend the scheduled study visits. 11.Individuals who are unable to comply with the instructions of the principal investigator or clinical trial staff. 12.Any other individuals deemed inappropriate for participation by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3D-Maze test | — |
Secondary
| Measure | Time frame |
|---|---|
| Testing for testosterone using saliva. | — |
Countries
Japan
Contacts
Public ContactNoriaki Komori
DKS Co. Ltd Basic R&D Group R&D Department Life Sciences Headquarters
Outcome results
None listed